Early Warning System for Diabetic Retinopathy in Type 2 Diabetes
Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus
Recruiting
Observational Study
Diabetes
Diabetic Retinopathy
Type 2 Diabetes Mellitus (T2DM)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 20 – 79
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,920 (estimated)
- Sponsor
- Yufan Wang · Other
Who this trial is looking for
This trial is looking for adults aged 20 to 79 with type 2 diabetes. Participants will help develop a model to better manage and treat diabetic retinopathy.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with type 2 diabetes.
- I am between 20 and 79 years old.
- I do not have severe underlying diseases.
- I can read and understand information.
- I want to take part in this study and can sign consent.
You may not be able to join if
- I have been diagnosed with type 1 diabetes.
- I have severe heart or lung problems.
- I have severe liver or kidney issues.
- I have mental confusion or dementia.
- I cannot take care of myself.
- I am currently pregnant or breastfeeding.
- I have had surgery or an infection recently.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to integrate clinical indicators and features of fundus images, combined with metabolomics, to construct an early warning model for diabetic retinopathy (DR) in type 2 diabetes. By combining clinical indicators with metabolomics, the investigators aim to establish a precise DR typing model based on the age of diabetes onset (early-onset diabetes, late-onset diabetes) and based on t…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Meets the diagnostic criteria for type 2 diabetes in the "China Type 2 Diabetes Prevention and Treatment Guidelines (2020 Edition)";
* Aged between 20 and 79 years old, without other severe underlying diseases; ③ Possesses full cognitive and literacy abilities; ④ Volunteers…
Contacts